“EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design”, J. Can. Res. Updates, vol. 5, no. 3, pp.  99–108, Jul. 2016, doi: 10.6000/1929-2279.2016.05.03.3.